Italiano
EnglishResults FY2021 (€/MLN)
1,237.7
REVENUES
543.1
ADJUSTED EBITDA
356.9
ADJUSTED NET PROFIT
300.7
FREE CASH FLOW
Press Releases
03/17/2023 - 22:05
DiaSorin Simplexa COVID Flu assay received U.S. FDA 510(K) clearance
